Beta Bionics (BBNX) Competitors $21.03 -1.20 (-5.40%) As of 10/10/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BBNX vs. NVST, SLNO, WRBY, LIVN, EYE, INSP, LMAT, AORT, PRCT, and LQDAShould you be buying Beta Bionics stock or one of its competitors? The main competitors of Beta Bionics include Envista (NVST), Soleno Therapeutics (SLNO), Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), Inspire Medical Systems (INSP), LeMaitre Vascular (LMAT), Artivion (AORT), PROCEPT BioRobotics (PRCT), and Liquidia Technologies (LQDA). These companies are all part of the "medical equipment" industry. Beta Bionics vs. Its Competitors Envista Soleno Therapeutics Warby Parker LivaNova National Vision Inspire Medical Systems LeMaitre Vascular Artivion PROCEPT BioRobotics Liquidia Technologies Beta Bionics (NASDAQ:BBNX) and Envista (NYSE:NVST) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations. Is BBNX or NVST more profitable? Envista has a net margin of 2.11% compared to Beta Bionics' net margin of 0.00%. Envista's return on equity of 4.84% beat Beta Bionics' return on equity.Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A Envista 2.11%4.84%2.68% Does the media refer more to BBNX or NVST? In the previous week, Beta Bionics had 3 more articles in the media than Envista. MarketBeat recorded 9 mentions for Beta Bionics and 6 mentions for Envista. Beta Bionics' average media sentiment score of 0.56 beat Envista's score of 0.24 indicating that Beta Bionics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation and earnings, BBNX or NVST? Beta Bionics has higher earnings, but lower revenue than Envista. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$65.12M14.04-$54.76MN/AN/AEnvista$2.51B1.26-$1.12B$0.3259.69 Do analysts rate BBNX or NVST? Beta Bionics currently has a consensus price target of $24.44, suggesting a potential upside of 16.24%. Envista has a consensus price target of $21.08, suggesting a potential upside of 10.35%. Given Beta Bionics' stronger consensus rating and higher possible upside, equities analysts plainly believe Beta Bionics is more favorable than Envista.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 1 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.69Envista 2 Sell rating(s) 10 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.24 SummaryBeta Bionics beats Envista on 7 of the 11 factors compared between the two stocks. Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BBNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBNX vs. The Competition Export to ExcelMetricBeta BionicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$914.17M$6.84B$6.04B$10.25BDividend YieldN/A1.18%5.73%4.79%P/E RatioN/A26.2986.5226.55Price / Sales14.04190.73616.63133.37Price / CashN/A21.8525.7330.17Price / Book-3.685.1112.866.52Net Income-$54.76M$178.04M$3.31B$276.31M7 Day Performance-4.19%-1.96%-0.74%-2.92%1 Month Performance-20.37%6.21%8.30%4.14%1 Year PerformanceN/A24.22%79.13%30.13% Beta Bionics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBNXBeta Bionics2.2701 of 5 stars$21.03-5.4%$24.44+16.2%N/A$914.17M$65.12M0.00294NVSTEnvista3.9698 of 5 stars$20.60+1.2%$20.92+1.6%+5.4%$3.38B$2.51B64.3612,300SLNOSoleno Therapeutics4.335 of 5 stars$57.98-3.6%$115.09+98.5%+16.5%$3.20BN/A-14.0030WRBYWarby Parker2.4142 of 5 stars$26.45-2.5%$24.06-9.0%+41.4%$2.85B$771.32M-377.753,780Positive NewsLIVNLivaNova2.6359 of 5 stars$51.23+1.2%$59.71+16.6%-3.5%$2.76B$1.25B-13.172,900EYENational Vision2.2485 of 5 stars$29.26+0.5%$24.73-15.5%+154.6%$2.30B$1.82B-162.5613,411INSPInspire Medical Systems4.8393 of 5 stars$74.16+2.5%$154.43+108.2%-64.3%$2.14B$802.80M42.871,246Analyst ForecastLMATLeMaitre Vascular3.8427 of 5 stars$86.87+0.2%$97.60+12.4%-5.0%$1.96B$234.64M42.17490AORTArtivion3.2725 of 5 stars$40.59-1.3%$43.13+6.3%+55.1%$1.94B$388.54M-96.631,600Analyst ForecastPRCTPROCEPT BioRobotics2.9332 of 5 stars$34.80+0.2%$70.00+101.1%-54.1%$1.93B$274.95M-22.45430LQDALiquidia Technologies3.3263 of 5 stars$21.90-0.7%$32.38+47.8%+109.5%$1.90B$14M-12.8850 Related Companies and Tools Related Companies Envista Competitors Soleno Therapeutics Competitors Warby Parker Competitors LivaNova Competitors National Vision Competitors Inspire Medical Systems Competitors LeMaitre Vascular Competitors Artivion Competitors PROCEPT BioRobotics Competitors Liquidia Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBNX) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
